On October 3, 2018, the week of our fifth anniversary, we processed and shipped our 40,000th FMT preparation. In partnership with stool donors and healthcare professionals across the country, these treatments have traveled to a network of more than 1,100 hospitals and clinics that have reshaped medical care for patients with recurrent C. difficile.
The pilot, open-label study is funded by Gates Foundation, Child Relief International and the Thrasher Research Fund.
SOMERVILLE, Mass. – This month, OpenBiome celebrated two notable milestones in its effort to expand safe access to fecal microbiota transplantation (FMT):
- OpenBiome partnered with its 1,000th clinical provider.
- OpenBiome shipped out its 30,000th treatment.
OpenBiome is pleased to announce a collaboration with the American Gastroenterological Association (AGA) on the Fecal Microbiota Transplantation (FMT) National Registry, planned to be the largest observational FMT study in history.